• Magazine
    • Past Issues
    • Subscribe
    • Change Mailing Address
    • Surveys
    • Guidelines for Authors
    • Editorial Calendar
    • Editorial Deadlines
  • Practice
    • Business Tips
    • Chiropractic Schools
    • Clinical & Technique
    • eBooks
    • eCourses
    • Infographics
    • Quizzes
    • Wellness & Nutrition
    • Personal Growth
    • Podcast
  • Resource Centers
  • Products & Services
    • Buyer’s Guide
    • Products Directory
    • Submit a Product
    • Vendor Login
  • Datebook
    • Become an Events Poster
    • Post an Event
    • View Events
  • Jobs
    • Jobs
    • Post a Job
  • Advertise
    • Advertising Information
    • Media Kit
    • Contact Us
    • Upload Advertising

Your Online Chiropractic Community

Chiropractic Economics Your Online Chiropractic Community
Subscribe
  • Home
  • Current Issue
  • News
  • Webinars
  • Chiropractic Research
  • Students
  • Coronavirus (COVID-19)

AHPA applauds FDA’s recall of tainted dietary supplements

Chiropractic Economics January 16, 2009

January 16, 2008 — The American Herbal Products Association (AHPA) applauds the U.S. Food and Drug Administration’s (FDA) efforts to recall and warn consumers about products marketed as dietary supplements that contain undeclared, active pharmaceutical ingredients.

FDA’s efforts align with AHPA’s mission to support the responsible commerce of dietary supplements.

Under the U.S. Food, Drug & Cosmetics Act (FDCA), products marketed as dietary supplements that contain undeclared, active pharmaceutical ingredients are illegal drugs and should be removed from the marketplace.

None of the products identified by FDA are marketed by members of AHPA or, to the best of AHPA’s knowledge, any other trade association in the dietary supplement industry. 

Source: American Herbal Products Association, www.ahpa.org

Related Posts

  • FDA finds ODI lists don’t prove ingredients were on market pre-DSHEAFDA finds ODI lists don’t prove ingredients were on market pre-DSHEA
  • AHPA asks FDA to withdraw labeling guidanceAHPA asks FDA to withdraw labeling guidance
  • FDA requests warnings on fluoroquinolone antimicrobial drugsFDA requests warnings on fluoroquinolone antimicrobial drugs
  • AHPA president discusses NDIs at ACS annual meetingAHPA president discusses NDIs at ACS annual meeting
  • AHPA announces ’09 board of trustees, officersAHPA announces ’09 board of trustees, officers
  • 2009 AHPA Awards honor herbal leaders2009 AHPA Awards honor herbal leaders

Filed Under: Industry News, News

Current Issue

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube logoYouTube logoYouTube

820 A1A N Highway W18,

Ponte Vedra Beach, FL 32082

Phone 904.285.6020

Fax 904.395.9118

CONTACT US »

Privacy Policy & Terms of Service

Copyright © 2021, All Rights Reserved

SUBSCRIBE TO THE MAGAZINE

Get Chiropractic Economics magazine
delivered to your home or office. Just
fill out our form to request your FREE
subscription for 20 issues a year,
including two annual Buyers Guides.

SUBSCRIBE NOW »

Latest Chiropractic News

  • Colorado allows chiropractors to give COVID-19 vaccine shots
  • American Chiropractic Association lauds U.S. Congress passing fair competition health legislation
    The American Chiropractic Association (ACA) lauded the U.S. Congress for passing legislation that will promote fair competition in health...
  • Logan University debuts new health center
    Logan University logo
x